Status:
COMPLETED
Effectiveness of the Individualized Metacognitive Training (EMC+) in People With Psychosis of Brief Evolution
Lead Sponsor:
Fundació Sant Joan de Déu
Collaborating Sponsors:
Parc Sanitari Sant Joan de Déu
Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
Conditions:
Brief Psychotic Disorder
Psychosis; Episode
Eligibility:
All Genders
18-45 years
Phase:
NA
Brief Summary
The main aim of the study is to evaluate the effectiveness of Individualized Meta-Cognitive Training (EMC +), in people with psychosis of brief evolution on symptoms, especially on positive symptoms. ...
Detailed Description
This is a randomized clinical trial in which some patients receive the EMC+ and others treatment as usual.The evaluator will be blind to the group to which the patients belong. The sample for the over...
Eligibility Criteria
Inclusion
- Diagnosis of : schizophrenia, schizoaffective disorder, brief psychotic disorder, delusional disorder, schizophreniform disorder, psychotic disorder not otherwise specified.
- Less than 5 years of evolution.
- Score at or above 4 on the PANSS during the last year (delusions, grandiosity, suspiciousness).
Exclusion
- Traumatic brain injury, dementia, or intellectual disability (premorbid IQ ≤70).
- Substance dependence.
- Score at or above 5 on the PANSS ( Hostility and Uncooperativeness); score at or above 6 on the PANSS (suspiciousness).
Key Trial Info
Start Date :
January 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2018
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT04429412
Start Date
January 1 2015
End Date
September 1 2018
Last Update
June 12 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.